Patel D, John J, Bodepudi R, Seher S, Khan S, Emmanuel S, et al. Role of Proprotein Convertase Subtilisin Kexin Type 9 Inhibitor Therapy in Treatment of Patients With Polycystic Ovary Syndrome: A Systemic Review of Metabolic and Cardiovascular Outcomes. Journal For International Medical Graduates [Internet]. 2024 Feb. 19 [cited 2026 Apr. 19];3(1). Available from: https://www.jimgs.com/ojs/index.php/journal/article/view/149